Drug Markets/EMPAGLIFLOZIN AND LINAGLIPTIN

EMPAGLIFLOZIN AND LINAGLIPTIN

6 NDCs across 1 manufacturers|0 Generic,6 Brand

Total NDCs

0G / 6B

Manufacturers

competing in market

Price Spread

$11.19 – $11.23

Up to 0% savings

7d Activity

6 flat

of 6 total NDCs

Monthly average NADAC price per unit, split by generic and brand

1 manufacturer producing EMPAGLIFLOZIN AND LINAGLIPTIN

6 NDCs total, 6 shown

Drug ↕	NDC	Manufacturer ↕	Price	Market Outlier	Class	7d Change ↕	Therapeutic Class
GLYXAMBI 10 MG-5 MG TABLET	00597018239	Boehringer Ingelheim Pharmaceuticals Inc.	$11.2263 per EA	—	Brand	—	Dipeptidyl Peptidase 4 Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor
GLYXAMBI 10 MG-5 MG TABLET	00597018290	Boehringer Ingelheim Pharmaceuticals Inc.	$11.2263 per EA	—	Brand	—	Dipeptidyl Peptidase 4 Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor
GLYXAMBI 10 MG-5 MG TABLET	00597018230	Boehringer Ingelheim Pharmaceuticals Inc.	$11.2263 per EA	—	Brand	—	Dipeptidyl Peptidase 4 Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor
GLYXAMBI 25 MG-5 MG TABLET	00597016430	Boehringer Ingelheim Pharmaceuticals Inc.	$11.1925 per EA	—	Brand	—	Dipeptidyl Peptidase 4 Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor
GLYXAMBI 25 MG-5 MG TABLET	00597016439	Boehringer Ingelheim Pharmaceuticals Inc.	$11.1925 per EA	—	Brand	—	Dipeptidyl Peptidase 4 Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor
GLYXAMBI 25 MG-5 MG TABLET	00597016490	Boehringer Ingelheim Pharmaceuticals Inc.	$11.1925 per EA	—	Brand	—	Dipeptidyl Peptidase 4 Inhibitor, Sodium-Glucose Cotransporter 2 Inhibitor